Rory B. Riggs, Director: Royalty Pharma RPRX Sell · Filed 23/05/22

Trade details

Type: Insider sale
Amount: $57,435,000
Shares · price: 1,750,000 sh · $32.82 a share
Held after: 6,762 sh
Stock: Royalty Pharma RPRX
Person: Rory B. RiggsDirector
Trade date: 23/05/22
Filed: 23/05/22
Days to filing: 0 days

Sold 99.6% of holdings

Share of holding sold: 99.6%

Royalty Pharma trades, last 26 weeks

What else happened in Royalty Pharma around then

Filed or reported within 30 days of the trade day · 23/04/22~23/06/21

Rory B. Riggs's recent trades

Rory B. RiggsDirector
SellIntra-Cellular Therapies
Sell
Intra-Cellular Therapies
ITCI
$337.2K
4,462 sh
$337.2K
Filed 24/06/25
Traded 24/06/24
Rory B. RiggsDirector
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$6.7M
235,200 sh
$6.7M
Filed 24/01/04
Traded 24/01/02
Rory B. RiggsDirector
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$5.5M
199,098 sh
$5.5M
Filed 24/01/04
Traded 24/01/03
Rory B. RiggsDirector
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$983.6K
35,702 sh
$983.6K
Filed 24/01/04
Traded 24/01/04
Rory B. RiggsCEO
BuyCibus
Buy
Cibus
CBUS
$5.5M
517,107 sh
$5.5M
Filed 23/12/14
Traded 23/12/12